Compare up to 40 stocks
Compared Stocks: 1 / 40
| Name | Sector | Price | Volume | Market Cap | P/E Ratio | Dividend Yield | Analyst Consensus | Analyst Price Target | Smart Score | Leveraged ETF | Article | Follow |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
 DHTRF | Healthcare | $13.47 | 10.50K | $748.45M | 12.04 | 3.14% | Strong Buy |
| Ticker | Company Name | Price | Change | % Change | |
|---|---|---|---|---|---|
| DHTRF | DRI Healthcare | 13.47 | 2.43 | 22.00% |
| Name | Price | % Change | |
|---|---|---|---|
| DHTRF | $13.47 | +22.00% |
Dri Healthcare Plc Trust (($TSE:DHT.UN)) has held its Q3 earnings call. Read on for the main highlights of the call. DRI Healthcare’s earnings call carried a strongly positive tone, with
Stifel raised the firm’s price target on DRI Healthcare Trust (DHTRF) to C$27.50 from C$27 and keeps a Buy rating on the shares. Published first on TheFly – the ultimate
An announcement from DRI Healthcare ( ($TSE:DHT.UN) ) is now available. DRI Healthcare Trust will release its third quarter 2026 financial results after markets close on November 4, 2026, and
Stifel raised the firm’s price target on DRI Healthcare Trust (DHTRF) to C$27 from C$26 and keeps a Buy rating on the shares. Published first on TheFly – the ultimate
DRI Healthcare ( ($TSE:DHT.UN) ) has provided an announcement. DRI Healthcare Trust is deepening its exposure to neurology royalties after the U.S. FDA approved Juvmo, a once-daily oral dopamine D1/D5
Analyst David Martin PhD of Bloom Burton maintained a Buy rating on DRI Healthcare, with a price target of C$23.00. David Martin PhD has given his Buy rating due to
RBC Capital raised the firm’s price target on DRI Healthcare Trust (DHTRF) to C$22 from C$21 and keeps an Outperform rating on the shares. Published first on TheFly – the
DRI Healthcare ( ($TSE:DHT.UN) ) has shared an announcement. DRI Healthcare Trust has agreed to acquire royalty participation rights in U.S. net sales of tavapadon from Bain Capital and NovaQuest
Dri Healthcare Plc Trust (($TSE:DHT.UN)) has held its Q2 earnings call. Read on for the main highlights of the call. Dri Healthcare Plc Trust’s latest earnings call struck a decidedly
DRI Healthcare ( ($TSE:DHT.UN) ) has provided an announcement. DRI Healthcare Trust reported record first-quarter total income of $50.6 million for 2026, supported by total cash receipts of $58.4 million
| Name | Upcoming Earnings Date | Market Cap | EPS Forecast | Sales Forecast | PEG Ratio | P/E Ratio |
|---|---|---|---|---|---|---|
| DHTRF | Mar 8, 2027TBA | $748.45M | $0.55 | $48.08M | -0.01 | 12.04 |
Compare Stocks Side-by-Side
Our stock comparison tool allows investors to compare multiple stocks simultaneously, providing comprehensive insights into key metrics, financial data, and analyst ratings. Make informed investment decisions by analyzing stocks side by side.
Key Features of Our Stock Comparison
How to Use the Stock Comparison Tool
Simply enter the ticker symbols of the stocks you want to compare in the search box above. You can add up to 40 stocks at once. The tool will automatically populate comparison tables with the latest data, allowing you to analyze and contrast different investment opportunities across various sectors and industries.
Popular Stock Comparisons
Investors frequently compare stocks within the same sector to identify the best investment opportunities. Popular comparisons include tech giants like Apple (AAPL) vs. Microsoft (MSFT), semiconductor leaders Nvidia (NVDA) vs. AMD, beverage companies Coca-Cola (KO) vs. Pepsi (PEP), and electric vehicle makers Tesla (TSLA) vs. Rivian (RIVN).
Why Compare Stocks?
Comparing stocks helps investors identify which companies offer the best value, growth potential, and risk-adjusted returns. By analyzing multiple stocks side by side, you can better understand relative valuations, competitive advantages, and market positioning before making investment decisions.
